Efficacy and safety of blinatumomab combination therapy in high-risk B-cell acute lymphoblastic leukemia: A systematic review and meta-analysis.

Oncol Lett · 2026 · PMC13051281 · PMID 41947896

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significanceP=0.060so close (0.05 < p ≤ 0.1)

The difference between subgroups approached but did not reach statistical significance (P=0.060) ( Fig. 6B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.